Alignment Healthcare CEO sells 250K shares
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported open-market sales of a total of 250,000 shares of Common Stock on April 7, 2026, through indirect holdings.
Rhea-AI Filing Summary
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported open-market sales of a total of 250,000 shares of Common Stock on April 7, 2026, through indirect holdings. The sales occurred at weighted-average prices of $20.67 and $21.3953 per share.
The indirectly held shares are owned by the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee. After these transactions, he continues to hold 2,104,641 shares indirectly and 1,784,868 shares directly. The sales were made pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 250,000 shares
Net Sell
3 txns
Insider
KAO JOHN E
Role
Chief Executive Officer
Sold
250,000 shs ($5.25M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 132,241 | $20.67 | $2.73M |
| Sale | Common Stock | 117,759 | $21.3953 | $2.52M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,104,641 shares (Indirect, See Footnote);
Common Stock — 1,784,868 shares (Direct)
Footnotes (4)
- F1. Date of Rule 10b5-1 plan adoption: 11/21/2025
- F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.18 to $21.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- F3. Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- F4. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.18 to $21.56. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Key Figures
Shares sold: 250,000 shares
First sale price: $20.67 per share
Second sale price: $21.3953 per share
+3 more
6 metrics
Shares sold
250,000 shares
Total Common Stock sold in open market on April 7, 2026
First sale price
$20.67 per share
Weighted-average price for 132,241 shares sold
Second sale price
$21.3953 per share
Weighted-average price for 117,759 shares sold
Indirect holdings after trades
2,104,641 shares
Common Stock held indirectly via JEK Trust after sales
Direct holdings
1,784,868 shares
Common Stock held directly after reported transactions
Rule 10b5-1 plan adoption date
November 21, 2025
Plan governing pre-scheduled insider trades
Key Terms
Rule 10b5-1 plan, weighted-average price, open-market sale, indirect ownership, +1 more
5 terms
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 11/21/2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"direct_or_indirect": "I","nature_of_ownership": "See Footnote""
JEK Trust financial
"Represents securities held by JEK Trust, dated February 8, 2021"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Alignment Healthcare (ALHC) CEO John E. Kao report in this Form 4?
John E. Kao reported selling 250,000 shares of Alignment Healthcare Common Stock in open-market transactions. The sales were executed through indirect holdings and disclosed as part of his insider ownership reporting obligations for transparency with shareholders and regulators.
Does this ALHC Form 4 include any derivative security exercises or only common stock sales?
This Form 4 reports only non-derivative Common Stock transactions, specifically open-market sales. The derivativeSummary section is empty and transaction details do not show any option exercises, conversions, or other derivative-related activity associated with these trades.
AI-generated analysis. How Rhea-AI works. Not financial advice.
